Cargando…

The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1

BACKGROUND: MicroRNAs (miRNAs) can serve as tumor suppressors and might provide an efficient strategy for annihilating tumor cells. Nevertheless, the potential role of miR-325 in hepatocellular carcinoma (HCC) is still unknown. METHODS: Using RT-PCR, immunoblots invasion assays and bioinformatics st...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huifen, Huang, Weihua, Luo, Rongcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509766/
https://www.ncbi.nlm.nih.gov/pubmed/26194496
http://dx.doi.org/10.1186/s13000-015-0323-z
_version_ 1782382079558811648
author Li, Huifen
Huang, Weihua
Luo, Rongcheng
author_facet Li, Huifen
Huang, Weihua
Luo, Rongcheng
author_sort Li, Huifen
collection PubMed
description BACKGROUND: MicroRNAs (miRNAs) can serve as tumor suppressors and might provide an efficient strategy for annihilating tumor cells. Nevertheless, the potential role of miR-325 in hepatocellular carcinoma (HCC) is still unknown. METHODS: Using RT-PCR, immunoblots invasion assays and bioinformatics strategies, we investigated the potential role of miR-325 in HCC. RESULTS: We showed that miR-325 was decreased and HMGB1 was increased in 99 patients with hepatocellular carcinoma. MiR-325 inhibition promoted cell invasion and proliferation, while miR-325 upregulation inhibited cell invasion and proliferation by using transwell and CCK8 assays. We further showed that HMGB1 might be a direct target of miR-325 and is negatively regulated by miR-325. Down-regulation of miR-325 predicts poor prognosis for HCC patients. CONCLUSIONS: These findings implied that miR-325 regulates cell invasion and proliferation via targeting HMGB1 and may be a potential prognostic marker for HCC. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/4655707031717989
format Online
Article
Text
id pubmed-4509766
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45097662015-07-23 The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1 Li, Huifen Huang, Weihua Luo, Rongcheng Diagn Pathol Research BACKGROUND: MicroRNAs (miRNAs) can serve as tumor suppressors and might provide an efficient strategy for annihilating tumor cells. Nevertheless, the potential role of miR-325 in hepatocellular carcinoma (HCC) is still unknown. METHODS: Using RT-PCR, immunoblots invasion assays and bioinformatics strategies, we investigated the potential role of miR-325 in HCC. RESULTS: We showed that miR-325 was decreased and HMGB1 was increased in 99 patients with hepatocellular carcinoma. MiR-325 inhibition promoted cell invasion and proliferation, while miR-325 upregulation inhibited cell invasion and proliferation by using transwell and CCK8 assays. We further showed that HMGB1 might be a direct target of miR-325 and is negatively regulated by miR-325. Down-regulation of miR-325 predicts poor prognosis for HCC patients. CONCLUSIONS: These findings implied that miR-325 regulates cell invasion and proliferation via targeting HMGB1 and may be a potential prognostic marker for HCC. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/4655707031717989 BioMed Central 2015-07-22 /pmc/articles/PMC4509766/ /pubmed/26194496 http://dx.doi.org/10.1186/s13000-015-0323-z Text en © Li et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Li, Huifen
Huang, Weihua
Luo, Rongcheng
The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
title The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
title_full The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
title_fullStr The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
title_full_unstemmed The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
title_short The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
title_sort microrna-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509766/
https://www.ncbi.nlm.nih.gov/pubmed/26194496
http://dx.doi.org/10.1186/s13000-015-0323-z
work_keys_str_mv AT lihuifen themicrorna325inhibitshepatocellularcarcinomaprogressionbytargetinghighmobilitygroupbox1
AT huangweihua themicrorna325inhibitshepatocellularcarcinomaprogressionbytargetinghighmobilitygroupbox1
AT luorongcheng themicrorna325inhibitshepatocellularcarcinomaprogressionbytargetinghighmobilitygroupbox1
AT lihuifen microrna325inhibitshepatocellularcarcinomaprogressionbytargetinghighmobilitygroupbox1
AT huangweihua microrna325inhibitshepatocellularcarcinomaprogressionbytargetinghighmobilitygroupbox1
AT luorongcheng microrna325inhibitshepatocellularcarcinomaprogressionbytargetinghighmobilitygroupbox1